Multimorbidity and polypharmacy: a risk factor for older patients

Main Article Content

Domenico Cucinotta


Multimorbidity, polypharmacy, older patients


Invited commentary on Letter: Acta Biomed 2022; Vol. 93, N. 2: e2022136 DOI 10.23750/abm.v93i2.12855



Download data is not yet available.
Abstract 27 | PDF Downloads 22


1) Linea Guida Intersocietaria per la gestione della comorbilità e della multipatologia .ISTITUTO SUPERIORE DI SANITÀ Italy, , 4 Giugno 2021
2) Polypharmacy Guidance Realistic Prescribing NHS Scotland 2018. 2018/04
3) Budnitz DS, et el Emergency hospitalizations for adverse drug events in older Americans. N. E. J. M. 2011;365(21):2002-12
4) htpp://DEPRESCRIBING.ORG Optimizing medication use
5) Rochon P.A. et al, Polypharmacy, inappropriate prescribing, and deprescribing in older people: through a sex and gender lens Lancet Healthy Longev 2021; 2: e290–300
6) International Association of Gerontology and Geriatrics European Region, Ex Com.2003